CCG-203971

• Description :

  CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  408.88

• Molecular Formula :

  C23H21ClN2O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Others

• CAS Number :

  1443437-74-8